Development of 3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-sulfate sodium salt (INT-767): Process optimization, synthesis and characterization of metabolites-Reference-Cited by-同舟云学术

Development of 3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-sulfate sodium salt (INT-767): Process optimization, synthesis and characterization of metabolites

Published:2022-11 Issue: Volume:242 Page:114652
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cerra Bruno,Venturoni Francesco,Souma Maria,Ceccarelli Giada,Lozza Anna Maria,Passeri Daniela,De Franco Francesca,Baxendale Ian R.,Pellicciari Roberto,Macchiarulo Antonio,Gioiello Antimo^ORCID

Funder

TES Pharma

Intercept Pharmaceuticals

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist;Rizzo;Mol. Pharmacol.,2010

2. The discovery of bbeticholic Acid (Ocaliva™): first-in-class FXR agonist;Pellicciari,2018

3. TGR5-mediated bile acid sensing controls glucose homeostasis;Thomas;Cell Metabol.,2009

4. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading;Pols;Cell Metabol.,2011

5. Central anorexigenic actions of bile acids are mediated by TGR5;Perino;Nat. Metab.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of action of the bile acid receptor TGR5 in obesity;Acta Pharmaceutica Sinica B;2024-02

2. Merging Continuous Flow Technology, Photochemistry and Biocatalysis to Streamline Steroid Synthesis;Advanced Synthesis & Catalysis;2023-06-05